Filing Details
- Accession Number:
- 0001968202-24-000094
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-17 16:06:52
- Reporting Period:
- 2024-05-16
- Accepted Time:
- 2024-05-17 16:06:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1226690 | George Yancopoulos | 777 Old Saw Mill River Road Tarrytown NY 10591 | Bd. Co-Chair, President & Cso | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-05-16 | 907 | $967.40 | 835,476 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-16 | 3,213 | $968.44 | 832,263 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-16 | 9,501 | $969.39 | 822,762 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-16 | 4,669 | $970.26 | 818,093 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-16 | 4,922 | $971.56 | 813,171 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-16 | 790 | $972.22 | 812,381 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-16 | 2,653 | $973.80 | 809,728 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-16 | 7,611 | $974.51 | 802,117 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-16 | 9,242 | $975.48 | 792,875 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-16 | 4,886 | $976.52 | 787,989 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-16 | 1,227 | $977.38 | 786,762 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-16 | 379 | $978.18 | 786,383 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,903 | Indirect | By 401(k) Plan |
| Common Stock | 180,000 | Indirect | By Trust for Chldn. |
| Common Stock | 158,410 | Indirect | by 2022 GRAT II |
| Common Stock | 18,148 | Indirect | by Children |
Footnotes
- Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on February 14, 2024.
- Represents volume-weighted average price of sales of 907 shares of Company stock on May 16, 2024 at prices ranging from $967.13 to $967.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
- Represents volume-weighted average price of sales of 3,213 shares of Company stock on May 16, 2024 at prices ranging from $968.04 to $968.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
- Represents volume-weighted average price of sales of 9,501 shares of Company stock on May 16, 2024 at prices ranging from $969.03 to $969.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
- Represents volume-weighted average price of sales of 4,669 shares of Company stock on May 16, 2024 at prices ranging from $970.00 to $970.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
- Represents volume-weighted average price of sales of 4,922 shares of Company stock on May 16, 2024 at prices ranging from $971.05 to $971.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
- Represents volume-weighted average price of sales of 790 shares of Company stock on May 16, 2024 at prices ranging from $972.00 to $972.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
- Represents volume-weighted average price of sales of 2,653 shares of Company stock on May 16, 2024 at prices ranging from $973.20 to $973.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
- Represents volume-weighted average price of sales of 7,611 shares of Company stock on May 16, 2024 at prices ranging from $974.00 to $974.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
- Represents volume-weighted average price of sales of 9,242 shares of Company stock on May 16, 2024 at prices ranging from $975.00 to $975.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
- Represents volume-weighted average price of sales of 4,886 shares of Company stock on May 16, 2024 at prices ranging from $976.00 to $976.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
- Represents volume-weighted average price of sales of 1,227 shares of Company stock on May 16, 2024 at prices ranging from $977.02 to $977.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
- Represents volume-weighted average price of sales of 379 shares of Company stock on May 16, 2024 at prices ranging from $978.07 to $978.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
- As investment trustee of trusts for the benefit of the reporting person's children.
Billionaire Hedge Funds
